Status:
COMPLETED
Feasibility Trial of the TELL Tool Intervention
Lead Sponsor:
University of Illinois at Chicago
Collaborating Sponsors:
National Institute of Nursing Research (NINR)
Conditions:
Fertility Issues
Disclosure
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
A radical paradigm shift is taking place where technology, notably the explosion in easy accessible direct-to-consumer genetic testing (e.g., 23andMe) and a high consumer interest in genealogy (e.g., ...
Detailed Description
The feasibility trail will use a longitudinal, mixed-methods design that is guided by International Patient Decision Aid Standards and NIH Guidelines for pilot studies. The study design is necessary t...
Eligibility Criteria
Inclusion
- Inclusion Criteria Parents:
- Reside in the United States or one of its recognized territories
- Conceived 1 or more children via gamete (egg/sperm) or embryo donation who are currently between the ages of 1 - 16 years of age
- Have not informed their child(ren) about their donor conception origins
- Are 21 years-of-age or older
- English speaking
- Inclusion Criteria Clinicians:
- Active practice as a healthcare professional (e.g., nurse, physician, psychologist, social worker)
- Provide education and/or counseling to gamete (eggs, sperm) and/or embryo donation recipient parents about disclosure to their children in the United States or one of its recognized territories
- Able to provide feedback and insight about new tools to assist gamete (eggs, sperm) and/or embryo donation recipient parents with disclosure to their donor-conceived children
- Are 21 years-of-age or older
- English speaking
- Exclusion Criteria Parents:
- Have already disclosed the donor conception to their donor-conceived child or children
- Reside outside of the United States or one of its recognized territories
- Exclusion Criteria Clinicians:
- Not directly involved in providing education and/or counseling to gamete (eggs, sperm) and/or embryo donation recipient parents about disclosure to their children
- Are a member of the research team
Exclusion
Key Trial Info
Start Date :
July 26 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2023
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT04841967
Start Date
July 26 2021
End Date
July 31 2023
Last Update
January 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Illinois at Chicago
Chicago, Illinois, United States, 60605